- Home
- WNW vs CNSP Comparison
WNW vs CNSP Comparison
Compare WNW & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNW
- CNSP
- Stock Information
- Founded
- WNW 2015
- CNSP 2017
- Country
- WNW China
- CNSP United States
- Employees
- WNW N/A
- CNSP N/A
- Industry
- WNW Catalog/Specialty Distribution
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- WNW Consumer Discretionary
- CNSP Health Care
- Exchange
- WNW Nasdaq
- CNSP Nasdaq
- Market Cap
- WNW 5.3M
- CNSP 5.6M
- IPO Year
- WNW 2020
- CNSP 2019
- Fundamental
- Price
- WNW $1.89
- CNSP $0.94
- Analyst Decision
- WNW
- CNSP Hold
- Analyst Count
- WNW 0
- CNSP 1
- Target Price
- WNW N/A
- CNSP N/A
- AVG Volume (30 Days)
- WNW 82.8K
- CNSP 212.2K
- Earning Date
- WNW 07-07-2025
- CNSP 08-13-2025
- Dividend Yield
- WNW N/A
- CNSP N/A
- EPS Growth
- WNW N/A
- CNSP N/A
- EPS
- WNW 9.06
- CNSP N/A
- Revenue
- WNW $158,485.00
- CNSP N/A
- Revenue This Year
- WNW N/A
- CNSP N/A
- Revenue Next Year
- WNW N/A
- CNSP N/A
- P/E Ratio
- WNW $0.20
- CNSP N/A
- Revenue Growth
- WNW N/A
- CNSP N/A
- 52 Week Low
- WNW $0.95
- CNSP $0.73
- 52 Week High
- WNW $70.00
- CNSP $148.00
- Technical
- Relative Strength Index (RSI)
- WNW 54.20
- CNSP 50.56
- Support Level
- WNW $1.74
- CNSP $0.73
- Resistance Level
- WNW $1.95
- CNSP $0.90
- Average True Range (ATR)
- WNW 0.19
- CNSP 0.08
- MACD
- WNW 0.03
- CNSP 0.02
- Stochastic Oscillator
- WNW 58.21
- CNSP 69.97
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.